Skip to main content

[12-02-2025] - Scan result

NIVI   

   12-02-2025   MMI - 31.89
We are experimenting on leveraging software models to scan large number of stocks and ETF (as of now around Stock - 700, ETF - 40 and increasing) to find out opportunity and trade.

As of now we are publishing daily scan results in this website for education purpose only. Requesting you to check those and let us know your comments/feedback which will help us to improve. Also, please share comments which all stocks/ETF you are interested.

Todays scan result for the educational purpose.

StrategySideScriptValueYesterday ClosePredictionConfidence
FallBy-6-DBuyALPHA-EQ45.9444.4843.68-177.88%
FallBy-6-DBuyFMCGIETF-EQ57.7856.6556.8293.81%
FallBy-6-DBuyICICIB22-EQ99.7297.4798.4199.37%
BuySellZone-DBuyTIMETECHNO-EQ341.3344.75370.6399.99%
BuySellZone-DBuyRAYMOND-EQ1418.521432.851435.0499.91%
BuySellZone-DBuyDREDGECORP-EQ650.0650.85646.6199.98%
BuySellZone-DBuyZAGGLE-EQ358.97362.6382.9499.62%
BuySellZone-DBuyWAAREERTL-B867.93876.7918.4699.5%

Trend Change:

ScriptDateCloseDayTrend
DIVISLAB-EQ07-02-20256140.55-3Down
INDIACEM-EQ07-02-2025278.85-3Down

Mutual Fund Details: (Selected)

CategoryNAV7Day Chg%1M Chg%
Quant Mid Cap Fund - Growth Option - Direct Plan223.6698-6.39-9.33
UTI Mid Cap Fund-Growth Option- Direct296.0561-5.34-12.63
*Edelweiss Mid Cap Fund - Direct Plan - Growth Option101.813-4.91-13.29
Kotak-Small Cap Fund - Growth - Direct279.754-4.78-13.16
*Quant Flexi Cap Fund - Growth Option-Direct Plan98.1882-4.21-7.26
Quant Small Cap Fund - Growth Option - Direct Plan249.3826-4.2-11.38
SBI Magnum Mid Cap Fund - Direct Plan - Growth241.985-4.14-7.86
*HSBC Value Fund - Direct Growth108.1713-3.96-9.5
SBI Small Cap Fund - Direct Plan - Growth178.8097-3.83-11.94
Axis Small Cap Fund - Direct Plan - Growth109.57-3.67-11.06
Tata Small Cap Fund-Direct Plan-Growth40.124-3.5-15.0
Aditya Birla Sun Life Multi-Cap Fund-Direct Growth18.44-3.36-10.53
*JM Flexicap Fund (Direct) - Growth Option106.1305-2.61-10.02
Bandhan Multi Cap Fund - Growth - Direct Plan16.247-2.48-7.45
*Motilal Oswal Midcap Fund-Direct Plan-Growth Option107.0499-2.34-17.54
Canara Robeco Focused Equity Fund - Direct Plan - Growth Option19.17-1.46-6.07
*Parag Parikh Flexi Cap Fund - Direct Plan - Growth86.86830.49-1.19
*SBI Contra Fund - Direct Plan - Growth394.3210.52-3.05
Axis Growth Opportunities Fund - Direct Plan - Growth33.280.69-5.0

Index PE Details:

Index P/E Index P/E Index P/E
Nifty Bank 12.9 Nifty Next 50 22.0 Nifty IT 31.8
Nifty Financial Services 15.4 Nifty 200 22.2 Nifty Alpha 50 33.7
Nifty 50 20.5 Nifty 500 23.1 Nifty Midcap 100 34.5
BSE Sensex 21.2 Nifty LargeMidcap 250 26.0 Nifty Midcap 50 39.2
Nifty Auto 21.7 Nifty Smallcap 250 28.8 NaN NaN


* Prediction and Accuracy value are in Development and Testing Stage of AI/ML Model


Disclaimer: We are not SEBI-registered advisors, and the information shared here is for educational, informational, or discussion purposes only. It should not be construed as financial advice or a recommendation to buy, sell, or hold any securities, ETFs, commodities, mutual funds, or other investments. We are not responsible for any profits or losses arising from any actions you take based on this information. Always consult with a qualified and SEBI-registered investment advisor before making any financial decisions.We may have an interest, exposure, or positions in the securities, ETFs, commodities, mutual funds, or other assets mentioned. This disclosure is made to ensure transparency regarding potential conflicts of interest.

Comments

Popular posts from this blog

Trendlyne Basket: NextIsValueInvesting

Check out basket of stock which we think can give multibagger returns Disclaimer: We are not SEBI Registered Advisors. This information is purely for educational purposes. We shall not be responsible for your profit or loss. Please confirm with your investment advisor. We do not provide any tips, advisory, solicitation, opinions or portfolio management services regarding buying, selling and trading of any securities, directly or indirectly, in any manner. Information displayed or laid out by us, including social media, are purely for either educational, informational, or discussion purposes and should not be construed as direct or indirect recommendation to invest, trade or speculate in the markets.

[07-01-2025] - Scan result

We are experimenting on leveraging software models to scan large number of stocks and ETF (as of now around Stock - 639, ETF - 38 and increasing) to find out opportunity and trade. As of now we are publishing daily scan results in this website for education purpose only. Requesting you to check those and let us know your comments/feedback which will help us to improve. Also, please share comments which all stocks/ETF you are interested. Todays scan result for the educational purpose. Strategy Side Script Value Yesterday Close Prediction Confidence BuySellZone-D Buy NATCOPHARM-EQ 1308.85 1308.85 1299.11 99.98% BBBSqueeze-D Buy KIMS-EQ 632.25 630.5 629.46 99.83% RSISMA-D Buy SAPPHIRE-EQ 351.72 354.4 352.72 99.8% BuySellZone-D Buy SUNTV-EQ 668.6 668.6 665.9 99.95% BuySellZone-D Buy JSL-EQ 664.15 664.15 665.98 99.99% NR7-D Buy THERMAX-EQ 4175.27 4153.55 4063.93 99.97% * Prediction and Accuracy value are in Development and Testing Stage of AI/ML Model

Trendlyne Basket: NIVI AI Optimizer

NIVI built AI Optimizer where in model assessed 630 stock and recommended stocks are in basket. Aim is for wealth creation over time. link: https://starfolio.trendlyne.com/public/basket/6608ebd413b24b8aab83331946e850a8/nivi-ai-optimizer/  Disclaimer: We are not SEBI Registered Advisors. This information is purely for educational purposes. We shall not be responsible for your profit or loss. Please confirm with your investment advisor. We do not provide any tips, advisory, solicitation, opinions or portfolio management services regarding buying, selling and trading of any securities, directly or indirectly, in any manner. Information displayed or laid out by us, including social media, are purely for either educational, informational, or discussion purposes and should not be construed as direct or indirect recommendation to invest, trade or speculate in the markets.